Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

SunEdison Meltdown Is Potential Discount for SUNE Stock

SunEdison is creating dubious headlines after a dismal earnings performance, but SUNE stock has a propensity for bouncing back from trouble.

Earnings Preview: Retail Stocks Hope to Reverse Bear Trend

Recent softening in U.S. consumer sentiment has major implications for retail stocks, many of which are releasing earnings results soon.

Food Stocks: Will It Be Feast or Famine? (SFM, WWAV, HSY)

A dwindling supply of food products coupled with stronger demand could be a bullish case for these three food stocks.

How to Trade the Berkshire Earnings Trend (BRK.B Stock)

World-famous Berkshire Hathaway stock comes with nuances that can be leveraged for extracting maximum gains from BRK.B stock.

3 Troubled Online Stocks: Zynga, Groupon and RetailMeNot

Lost in the impressive performance of the Nasdaq Composite Index are online stocks that have stalled in 2015: Which ones can make a comeback?

Don’t Be Fooled By WYNN Stock’s After-Earnings Jump (WYNN)

Casinos face a murky future as the industry declines, leaving Wynn Resorts scrambling for answers with yet another WYNN stock earnings miss.

3 Chinese Stocks Falling After Earnings (SOHU, BIDU, CYOU)

Despite scoring major points in recent earnings releases, Chinese stocks have been utterly gutted, leaving serious questions for the sector.

Biotech Stocks Earnings Preview (ABBV, BIIB, UTHR)

We're in the year of biotech stocks, which easily outpaced the broad S&P 500. With earnings season in bloom, can they keep the magic alive?

Spinoff Rumors And Nintendo Won’t Save AMD stock (AMD)

Attempts by Advanced Micro Devices to bolster AMD stock with lucrative deals just won't work. The financials are too far gone to correct.

The Latest Putin Dustup Could Sink the RSX ETF

Perennial bad-boy Vladimir Putin is up to his old tricks again, his testing of Western resolve threatening the stability of the RSX ETF.